Vaccinex, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $90.0K |
| Cost of Revenue | $160.0K |
| Gross Profit | $-70.0K |
| Gross Margin | -77.8% |
| Operating Expenses | |
| Research & Development | $16.6M |
| SG&A Expense | $4.5M |
| Operating Income | $-21.1M |
| Operating Margin | -23,448.9% |
| Interest Expense | $1.4M |
| Pretax Income | $-18.8M |
| Income Tax Expense | $0 |
| Net Income | $-18.7M |
| Net Margin | -20,802.2% |
| EPS (Basic) | $-3.98 |
| EPS (Diluted) | $-3.98 |
| Shares Outstanding (Basic) | 5.5M |
| Shares Outstanding (Diluted) | 5.5M |
| Dividends Per Share | — |